Iryanthera paraensis
Connections displayed (default: 10).
Loading graph...
| Scientific Name | Iryanthera paraensis |
|---|---|
| Database Name | cmaup_plants |
| Synonyms | Iryanthera Paraensis |
| Ipni Id | 130222-2 |
| Plant Name | Iryanthera Paraensis |
| Genus Tax Id | 224860 |
| Disease Name | Endometrial cancer, Parkinsonism, Colorectal cancer, Non-small cell lung cancer, Unspecified viral infection of unspecified site, Thyroid cancer, Gout, Cardiovascular disease, Breast cancer, Inborn purine/pyrimidine/nucleotide metabolism error, Stomach cancer, Mature B-cell lymphoma, Malignant haematopoietic neoplasm, Hepatitis virus infection, Testicular cancer, Chemoprotection, Insomnia, HIV-infected patients with tuberculosis, Chronic pain, Inborn lipid metabolism error, Influenza, Acute myeloid leukaemia, Head and neck cancer, Ischemic heart disease, Carcinoid syndrome, Metastatic lymph node neoplasm, Essential hypertension, Leiomyosarcoma, Autism spectrum disorder, Renal cell carcinoma, Liver cancer, Motor neuron disease, Lung cancer, Multiple myeloma, Cushing syndrome, Ovarian cancer, Pancreatic cancer, Kaposi sarcoma, Mild neurocognitive disorder, Pituitary gland disorder, Myelodysplastic syndrome, Biliary tract cancer, Solid tumour/cancer, Nasopharyngeal cancer, Peritoneal cancer, Endometriosis, Pleomorphic sarcoma, Autonomic nervous system disorder, Psoriasis, Colon cancer, Multiple sclerosis, Malignant mesenchymal neoplasm, Oesophageal/gastroduodenal disorder, Follicular lymphoma, Acquired hypermelanosis, Brain cancer, Bacterial infection, Osteosarcoma, Low bone mass disorder, Crohn disease, Mature T-cell lymphoma, Extraocular muscle disorder, Bladder cancer, Glaucoma, Transplant rejection, Melanoma, Idiopathic interstitial pneumonitis, Asthma, Human immunodeficiency virus disease, Acquired hypomelanotic disorder, Skin postprocedural disorder, Ovarian dysfunction, Ewing sarcoma, Oesophagitis, Gonococcal infection, Transplanted organ/tissue, Ischemia, Atopic eczema, Thrombocytopenia, Urinary tract infection, Thyrotoxicosis, Attention deficit hyperactivity disorder, Metastatic liver/bile duct neoplasm, Cervical cancer, Myeloproliferative neoplasm, Chronic arterial occlusive disease, Filariasis, Parasitic worm infestation, Fallopian tube cancer, Retinopathy, Pain, unspecified, Diffuse large B-cell lymphoma, Diabetic foot ulcer, BCR-ABL1-negative chronic myeloid leukaemia, Ocular cancer, Chronic kidney disease, Common warts, Substance abuse, Hypopharyngeal cancer, Spinal cord/cranial nerve neoplasm, Alzheimer disease, Kidney failure, Unspecific body region injury, Seborrhoeic dermatitis, Esophageal cancer, Multiple structural anomalies syndrome, Thrombosis, Rheumatoid arthritis, Unspecific substance harmful effect, Otitis externa, Coronavirus infection, Mature B-cell leukaemia, Metastatic malignant neoplasm, Bone/articular cartilage neoplasm, Postoperative inflammation, Myasthenia gravis, Malignant digestive organ neoplasm, Acute diabete complication, Mineral deficiency, Urethral cancer, Dementia, Liver disease, Synovial sarcoma, Ureteral cancer, Angina pectoris, Pediculosis, Myocardial infarction, Otitis media, Mastocytosis, Epidermal dysplasias, Irritable bowel syndrome, Fungal infection, Chronic myelomonocytic leukaemia, Syphilis, Anogenital warts, Duodenal ulcer, Metabolic disorder, Heart failure, Gastrointestinal stromal tumour, Intracerebral haemorrhage, Encephalopathy, Prostate cancer, Neuropathy, Metastatic biliary tract neoplasms, Diabetes mellitus, type unspecified, Digestive organ benign neoplasm, Metastatic digestive system neoplasm, Inflammatory arthropathy, General pain disorder, Phakomatoses/hamartoneoplastic syndrome, Lip/oral cavity/pharynx neoplasm, Type 2 diabetes mellitus, Liposarcoma, Respiratory system disease, Congenital aplastic anaemia, Ageing associated decline in intrinsic capacity, Macular degeneration, COVID-19, Adenocarcinoma of prostate, Sickle-cell disorder, Tension-type headache, coronary artery disease, Other specified non-alcoholic fatty liver disease, Malignant neoplasms of other or unspecified parts of mouth, Nephrocalcinosis, Osteoarthritis, Xerostomia, Unspecified malignant neoplasms of unspecified sites, Cataract, Gastro-oesophageal reflux disease, Lichen planus, Chronic hepatitis C, Kidney failure, unspecified, Chronic obstructive pulmonary disease, Cystic fibrosis, Cholelithiasis, Carcinosarcoma of uterus, Coeliac disease, Serous cystadenoma,borderline malignancy of ovary, Pheochromocytoma, Myelodysplastic syndromes, unspecified, Inflammatory bowel diseases, unspecified, Zika virus disease, Osteoarthritis, unspecified, Dengue fever, unspecified, Malignant neoplasms of biliary tract, distal bile duct, Hepatoblastoma, Leishmaniasis, Adenocarcinoma of stomach, Atrial fibrillation, Malignant neoplasm metastasis in lymph nodes of head, face or neck, Diffuse large B-cell lymphomas, Myotonic dystrophy, Other specified malignant neoplasms of kidney, except renal pelvis, Keratoconus, Squamous cell carcinoma of bronchus or lung, West Nile virus infection, Adenocarcinoma of pancreas, Mesothelioma of pleura, Pre-eclampsia, Tetralogy of Fallot, Other specified malignant neoplasms ofcolon, Melanoma of skin, Pneumonia due to Pseudomonasaeruginosa, Hepatocellular carcinoma of liver, Other specified malignant neoplasms of bronchus or lung, Superficial ovarian endometriosis, Malignant neoplasms of oesophagus, Urothelial carcinoma of bladder, Cytomegaloviral disease, Systemic sclerosis, Chronic rhinosinusitis, Systemic lupus erythematosus, Malignant neoplasms of thyroid gland, unspecified, Adenocarcinoma of bronchus or lung, Malignant neoplasms of corpus uteri, unspecified, Chikungunya virus disease, Polycystic ovary syndrome, Dilated cardiomyopathy, Malignant neoplasms of thymus, Invasive carcinoma of breast, Heart failure, unspecified, Human immunodeficiency virus disease without mention of tuberculosis or malaria, Glioblastoma of brain, Renal cell carcinoma, chromophobe type, Germ cell tumour of testis, Carpal tunnel syndrome, Ebola virus disease, Malignant neoplasms of adrenal gland, Lyme borreliosis, Gliomas of brain |
| Genus Name | Iryanthera |
| Disease Id | 2C76, 8A00, 2B91, 2C25, 1D9Z, 2D10, FA25, BA00-BE2Z, 2C60-2C6Y, 5C55, 2B72, 2A85, 2B33, 1E50-1E51, 2C80, N.A., 7A00-7A0Z, 1B10-1B14, MG30, 5C52, 1E30-1E32, 2A60, 2D42, BA40-BA6Z, 5B10, 2D60, BA00, 2B58, 6A02, 2C90, 2C12, 8B60, 2A83, 5A70, 2C73, 2C10, 2B57, 6D71, 5A60-5A61, 2A37, 2C17, 2A00-2F9Z, 2B6B, 2C51, GA10, 2B54, 8D87, EA90, 2B90, 8A40, 2B5D-2B5Y, DD90, 2A80, ED60, 2A00, 1A00-1C4Z, 2B51, FB83, DD70, 2A90, 9C82, 2C94, 9C61, NE84, 2C30, CB03, CA23, 1C60-1C62, ED63, EL8Y, 5A80, 2B52, DA24, 1A70-1A7Z, QB63, 8B10-8B11, EA80, 3B64, GC08, 5A02, 6A05, 2D80, 2C77, 2A20, BD4Z, 1F66, 1F90, 2C74, 9B71, MG3Z, 2A81, BD54, 2A41, 2D00-2D07, GB61, 1.00E+80, 6C40, 2B6D, 2A02, 8A20, GB60-GB6Z, ND56, EA81, 2B70, LD2F, DB61-GB90, FA20, NE6Z, AA00-AA13, 1D92, 2A82, 2D50-2E09, 2F7B, 1A00-CA43, 8C6Y, 2C11, 5A2Y, 5B5K, 2C93, 6D80-6D8Z, DB90-DB9Z, 2B5A, 2C92, BA40, 1G00, BA41-BA43, AA80-AB0Z, 2A21, EK90, DD91, 1F29-1F2F, 2A40, 1A61-1A6Z, 1A95, DA63, 5C50-5D2Z, BD10-BD1Z, 2B5B, 8B00, 8.00E+47, 2C82, 8C0Z, 2C14-2C17, 5A14, 2.00E+92, 2D8Y, FA2Z, 8.00E+43, LD2D, 2B6E, 5A11, 2B59, CB40-CB7Z, 3A70.0, MG2A, 9B75, 1D6Y, 2C82.0, 3A51, 8A81, BA8Y-BA8Z, DB92.Y, 2B66, GB57, FA00-FA05, DA02.1, 2D4Z, 9B10, DA22, EA91, 1E51.1, GB6Z, CA22, CA25, DC11, 2C76.43, DA95, 2C73.4, XH3854, 2A3Z, DD7Z, 1D48, FA0Z, 1D2Z, 2C15, 2C12.01, 1F54, 2B72.0, BC81.3, 2D60.0, 8C71.0, 2C90.Y, 9A78.50, 2C25.2, 1D46, 2C10.0, 2C26.0, JA24, LA88.2, 2B90.Y, CA40.05, 2C12.02, 2C25.Y, GA10.B4, 2C94.2, 1D82, 4A42, CA0A, 4A40.0, 2D10.Z, 2C25.0, 2C76.Z, 1D40, 5A80.1, BC43.0, 2C27, 2C61, BD1Z, 1C62, 2A00.00, XH6153, 2C80.2, 8C10.0, 1D60.01, 2D11, 1C1G, 2A00.0 |
| Family Name | Myristicaceae |
| Family Tax Id | 22274 |
- 1. (+)-3-Carene (PubChem CID: 443156)
- 2. (+)-Beta-Phellandrene (PubChem CID: 442484)
- 3. (-)-Larreatricin (PubChem CID: 26389403)
- 4. (-)-Sabinene (PubChem CID: 11051711)
- 5. (2e,4e,6e)-N-Isobutyl-7-(2-Thienyl)-2,4,6-Heptatrienamide (PubChem CID: 73349612)
- 6. (2e,4e,6e)-N-Isopentyl-7-(2-Thienyl)-2,4,6-Heptatrienamide (PubChem CID: 72696080)
- 7. (2r,3r,4r,5r,6s)-2-[[(2r,3s,4s,5r,6s)-6-[5,7-Dihydroxy-2-(4-Hydroxy-3,5-Dimethoxyphenyl)chromenylium-3-Yl]oxy-3,4,5-Trihydroxyoxan-2-Yl]methoxy]-6-Methyloxane-3,4,5-Triol (PubChem CID: 101942241)
- 8. (2s,3r,4r,5r,6r)-2-[2-(3,4-Dihydroxyphenyl)-5,7-Dihydroxychromenylium-3-Yl]oxy-6-(Hydroxymethyl)oxane-3,4,5-Triol (PubChem CID: 12303205)
- 9. (2s,3s,4r,5r)-2-[5,7-Dihydroxy-2-(3,4,5-Trihydroxyphenyl)chromenylium-3-Yl]oxyoxane-3,4,5-Triol (PubChem CID: 101603499)
- 10. (4as,5s,6r,8ar)-5-[2-(Furan-3-Yl)ethyl]-5,6,8a-Trimethyl-3,4,4a,6,7,8-Hexahydronaphthalene-1-Carboxylic Acid (PubChem CID: 15559628)
- 11. (6r,9s)-Roseoside (PubChem CID: 11165077)
- 12. (E,e)-1,4,4-Trimethyl-8-Methylene-1,5-Cycloundecadiene (PubChem CID: 5318102)
- 13. 2',4'-Dihydroxy-6'-Methoxy-3,4-Methylenedioxydihydrochalcone (PubChem CID: 14261270)
- 14. 2,4-Dodecadienamide, N-(2-Methylpropyl)-, (2e,4e)- (PubChem CID: 6443006)
- 15. 2-(3,4-Dihydroxyphenyl)-5,7-Dihydroxy-3-[(2s,3r,4s,5s,6r)-3,4,5-Trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxymethyl]oxan-2-Yl]oxychromen-4-One (PubChem CID: 162942602)
- 16. 2-(3,4-Dihydroxyphenyl)-5,7-Dihydroxy-3-[(2s,3r,4s,5s,6s)-3,4,5-Trihydroxy-6-Methyloxan-2-Yl]oxychromen-4-One (PubChem CID: 162903257)
- 17. 2-(3,4-Dihydroxyphenyl)-5,7-Dihydroxy-3-[(2s,3s,4r,5s,6s)-3,4,5-Trihydroxy-6-[[(2s,3s,4r,5s,6r)-3,4,5-Trihydroxy-6-Methyloxan-2-Yl]oxymethyl]oxan-2-Yl]oxychromen-4-One (PubChem CID: 162995328)
- 18. 2-Naphthol (PubChem CID: 8663)
- 19. 4-[(1s,2'r,3r,5's,6r)-1,3,5'-Tris(4-Hydroxyphenyl)-3'-Methylidenespiro[3,4,5,7-Tetrahydro-1h-2-Benzofuran-6,4'-Oxolane]-2'-Yl]phenol (PubChem CID: 162973047)
- 20. 4-[(2r,3r,4s,5s)-5-(4-Hydroxyphenyl)-3,4-Dimethyloxolan-2-Yl]-2-[(2r)-1-(4-Hydroxyphenyl)propan-2-Yl]phenol (PubChem CID: 162961409)
- 21. 4-[(2r,3s,4r,5s)-5-(4-Hydroxyphenyl)-3,4-Dimethyloxolan-2-Yl]-2-[(2r)-1-(4-Hydroxyphenyl)propan-2-Yl]phenol (PubChem CID: 162961410)
- 22. 4-[(2r,5r)-5-(4-Hydroxy-3-Methoxyphenyl)-3,4-Dimethyl-2,5-Dihydrofuran-2-Yl]-2-Methoxyphenol (PubChem CID: 73213069)
- 23. 4-[(2r,5r)-5-(4-Hydroxyphenyl)-3,4-Dimethyl-2,5-Dihydrofuran-2-Yl]phenol (PubChem CID: 25775479)
- 24. 4-[(2s,3r,5s)-5-(4-Hydroxy-3-Methoxyphenyl)-3-Methyl-4-Methylideneoxolan-2-Yl]-2-Methoxyphenol (PubChem CID: 73213151)
- 25. 4-[(2s,3r,5s)-5-(4-Hydroxyphenyl)-3-Methyl-4-Methylideneoxolan-2-Yl]phenol (PubChem CID: 73213070)
- 26. 4-[(2s,3s,4s,5r)-5-[4-Hydroxy-3-[(2r)-1-(4-Hydroxyphenyl)propan-2-Yl]phenyl]-3,4-Dimethyloxolan-2-Yl]benzene-1,2-Diol (PubChem CID: 162858402)
- 27. 4-Terpineol, (+)- (PubChem CID: 2724161)
- 28. 5,7-Dihydroxy-2-(3,4,5-Trihydroxyphenyl)-3-[(2s,3r,4s,5s,6r)-3,4,5-Trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxymethyl]oxan-2-Yl]oxychromen-4-One (PubChem CID: 162856353)
- 29. 5,7-Dihydroxy-2-(4-Hydroxyphenyl)-3-[(2s,3r,4r,5r,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxychromen-4-One (PubChem CID: 12358426)
- 30. 5,7-Dihydroxy-2-(4-Hydroxyphenyl)-3-[(2s,3s,4r,5s,6s)-3,4,5-Trihydroxy-6-[[(2r,3r,4r,5s,6s)-3,4,5-Trihydroxy-6-Methyloxan-2-Yl]oxymethyl]oxan-2-Yl]oxychromen-4-One (PubChem CID: 162951776)
- 31. 5-[(Z,11s)-11-Hydroxyheptadec-8-Enyl]benzene-1,3-Diol (PubChem CID: 23626633)
- 32. [(1r,2s,6s,7r,8s,9r,11s,13s,14s,15r,16s,17r)-2,11,15,16-Tetrahydroxy-9,13,17-Trimethyl-4,12-Dioxo-5,18-Dioxapentacyclo[12.5.0.01,6.02,17.08,13]nonadecan-7-Yl] (E)-2-Methylbut-2-Enoate (PubChem CID: 101046538)
- 33. [(2r,3s,4s,5r,6s)-6-[2-(3,4-Dihydroxyphenyl)-5,7-Dihydroxychromenylium-3-Yl]oxy-3,4,5-Trihydroxyoxan-2-Yl]methyl (E)-3-(4-Hydroxyphenyl)prop-2-Enoate (PubChem CID: 5282067)
- 34. [(E)-2-Cyano-4-[(2r,3r,4s,5s,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxybut-2-Enyl] (E)-3-(4-Hydroxy-3-Methoxyphenyl)prop-2-Enoate (PubChem CID: 11972424)
- 35. [(E)-2-Cyano-4-[(2r,3r,4s,5s,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxybut-2-Enyl] (E)-3-(4-Hydroxyphenyl)prop-2-Enoate (PubChem CID: 11972423)
- 36. [3-(3,4-Dihydroxyphenyl)-7-(4-Hydroxyphenyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxy-2,8-Dioxatricyclo[7.3.1.05,13]trideca-1(12),3,5(13),6,9-Pentaen-11-Ylidene]oxidanium (PubChem CID: 101198724)
- 37. [7-(4-Hydroxyphenyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxy-3-(3,4,5-Trihydroxyphenyl)-2,8-Dioxatricyclo[7.3.1.05,13]trideca-1(12),3,5(13),6,9-Pentaen-11-Ylidene]oxidanium (PubChem CID: 101198725)
- 38. Alpha-Pinene, (+)- (PubChem CID: 82227)
- 39. Astragalin (PubChem CID: 5282102)
- 40. Beta-Ocimene, (3e)- (PubChem CID: 5281553)
- 41. Beta-Ocimene, (3z)- (PubChem CID: 5320250)
- 42. Beta-Sitosterol (PubChem CID: 222284)
- 43. Cannabiscitrin (PubChem CID: 5486615)
- 44. Caryophyllene (PubChem CID: 5281515)
- 45. Cid 36690979 (PubChem CID: 36690979)
- 46. Cinchonain I A (PubChem CID: 44575965)
- 47. Cyanidin 3-Glucoside (PubChem CID: 441667)
- 48. Delphinidin 3-O-Glucoside Cation (PubChem CID: 443650)
- 49. Delphinidin 3-Rutinoside (PubChem CID: 5492231)
- 50. Delphinidin-3-O-(6-P-Coumaroyl)glucoside (PubChem CID: 15922818)
- 51. Epicatechin (PubChem CID: 72276)
- 52. Epicatechin Gallate (PubChem CID: 107905)
- 53. Gallic Acid (PubChem CID: 370)
- 54. Gallocatechin-(4alpha->8)-Epigallocatechin (PubChem CID: 442682)
- 55. Gallocatechin-(4alpha->8)-Gallocatechin-(4alpha->8)-Gallocatechin (PubChem CID: 71664720)
- 56. Homobutein (PubChem CID: 6438092)
- 57. Hyperoside (PubChem CID: 5281643)
- 58. Icariside B1 (PubChem CID: 15628136)
- 59. Isocryptomerin (PubChem CID: 5318537)
- 60. Isoquercetin (PubChem CID: 5280804)
- 61. Kaempferol (PubChem CID: 5280863)
- 62. Kaempferol 3-O-Beta-L-Glucopyranoside (PubChem CID: 9911508)
- 63. Keracyanin Cation (PubChem CID: 441674)
- 64. Limonene, (+)- (PubChem CID: 440917)
- 65. Malvidin 3-O-Beta-D-Glucoside (PubChem CID: 443652)
- 66. Meso-3,3'-Didemethoxynectandrin B (PubChem CID: 14213224)
- 67. Methyl (2e)-3-(4-Hydroxyphenyl)prop-2-Enoate (PubChem CID: 92203)
- 68. Methyl Gallate (PubChem CID: 7428)
- 69. Myricetin (PubChem CID: 5281672)
- 70. Myricetin 3-O-Alpha-L-Glucopyranoside (PubChem CID: 72551451)
- 71. Myricetin 3-O-Beta-D-Glucopyranoside (PubChem CID: 5318606)
- 72. Oleiferin C (PubChem CID: 9974649)
- 73. Oleiferin D (PubChem CID: 44450596)
- 74. P-Cymen-8-Ol (PubChem CID: 14529)
- 75. Pelargonidin 3-Glucoside Ion (PubChem CID: 443648)
- 76. Pelargonidin 3-O-Rutinoside (PubChem CID: 443917)
- 77. Peonidin 3-Rutinoside (PubChem CID: 90470732)
- 78. Peonidin-3-Glucoside (PubChem CID: 443654)
- 79. Petunidin 3-O-Glucoside (PubChem CID: 443651)
- 80. Petunidin 3-Rutinoside (PubChem CID: 101949843)
- 81. Prodelphinidin B3 (PubChem CID: 13831068)
- 82. Quercetin (PubChem CID: 5280343)
- 83. Rhodinol (PubChem CID: 81263)
- 84. Terpinolene (PubChem CID: 11463)
- 85. Tyrosol (PubChem CID: 10393)
- 1. Alzheimer's Disease 1
- 2. Arthritis
- 3. Arthritis, Gouty
- 4. Arthritis, Rheumatoid
- 5. Asthma
- 6. Cardiovascular Diseases
- 7. Cataract
- 8. Celiac Disease
- 9. Chancre
- 10. Cholelithiasis
- 11. Cholera
- 12. Common Wart
- 13. Coronary Artery Disease
- 14. Crohn Disease
- 15. Cystic Fibrosis
- 16. Dementia
- 17. Diabetes Mellitus
- 18. Esophagitis
- 19. Filariasis
- 20. Glaucoma
- 21. Gonorrhea
- 22. Inflammatory Bowel Diseases
- 23. Influenza, Human
- 24. Liver Neoplasms
- 25. Lupus Erythematosus, Systemic
- 26. Myocardial Infarction
- 27. Osteoarthritis
- 28. Pre-Eclampsia
- 29. Psoriasis
- 30. Scleroderma, Systemic
- 31. Thrombocytopenia
- 32. Urinary Tract Infections
Not listed in any formulations.